These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 39089987)

  • 1. Utilization of antiobesity medications within the Military Health System.
    Neuman T; Corrado R; Banaag A; Koehlmoos TP
    Obesity (Silver Spring); 2024 Oct; 32(10):1825-1832. PubMed ID: 39089987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Body Mass Index Effect on Health Service Utilization Among Active Duty Male United States Army Soldiers.
    Shiozawa B; Madsen C; Banaag A; Patel A; Koehlmoos T
    Mil Med; 2019 Oct; 184(9-10):447-453. PubMed ID: 30811530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic outcomes of antiobesity medication use among adults in the United States: A retrospective cohort study.
    Watkins S; Toliver JC; Kim N; Whitmire S; Garvey WT
    J Manag Care Spec Pharm; 2022 Oct; 28(10):1066-1079. PubMed ID: 35856489
    [No Abstract]   [Full Text] [Related]  

  • 4. Real-world primary nonadherence to antiobesity medications.
    Kan H; Bae JP; Dunn JP; Buysman EK; Gronroos NN; Swindle JP; Bengtson LGS; Ahmad N
    J Manag Care Spec Pharm; 2023 Oct; 29(10):1099-1108. PubMed ID: 37594848
    [No Abstract]   [Full Text] [Related]  

  • 5. Caring for Service Members Who Have Been Sexually Assaulted: The Military Health System.
    Murray AL; Perez Koehlmoos T; Banaag A; Schvey NA
    Mil Med; 2023 Jul; 188(7-8):1609-1614. PubMed ID: 35751587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiobesity Medication Use Among Overweight and Obese Adults in the United States: 2015-2018.
    MacEwan J; Kan H; Chiu K; Poon JL; Shinde S; Ahmad NN
    Endocr Pract; 2021 Nov; 27(11):1139-1148. PubMed ID: 34265455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Active Duty Service Members Newly Presenting With Low Back Pain in Fiscal Year 2017: Health Care Utilization, Access to Care, and Private Sector Costs Over 2-year Follow-up.
    Yuan X; Pav V; Colahan C; Miller ME; Hager NA; Pasquina PF; Cohen SP; Isaacson BM
    Mil Med; 2023 Jul; 188(7-8):e2387-e2396. PubMed ID: 36433751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of obesity prevalence: military health system and United States populations, 2009-2012.
    Eilerman PA; Herzog CM; Luce BK; Chao SY; Walker SM; Zarzabal LA; Carnahan DH
    Mil Med; 2014 May; 179(5):462-70. PubMed ID: 24806489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prevalence of M. tuberculosis among acid fast bacilli cultures from military health system and veterans affairs beneficiaries in Hawaii and the Pacific Islands from 2002 to 2019.
    Crecelius EM; Lustik MB; Horseman TS; Jones MU
    PLoS One; 2021; 16(7):e0254312. PubMed ID: 34242307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse event comparison between glucagon-like peptide-1 receptor agonists and other antiobesity medications following bariatric surgery.
    Samuels JM; Niswender KD; Roumie CL; Spann MD; Flynn CR; Ye F; Blankush J; Irlmeier R; Funk LM; Patel MB
    Diabetes Obes Metab; 2024 Sep; 26(9):3906-3913. PubMed ID: 38934217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacotherapy for the Treatment of Overweight and Obesity in Children, Adolescents, and Young Adults in a Large Health System in the US.
    Czepiel KS; Perez NP; Campoverde Reyes KJ; Sabharwal S; Stanford FC
    Front Endocrinol (Lausanne); 2020; 11():290. PubMed ID: 32477270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purchased Behavioral Health Care Received by Military Health System Beneficiaries in Civilian Medical Facilities, 2000-2014.
    Wooten NR; Brittingham JA; Pitner RO; Tavakoli AS; Jeffery DD; Haddock KS
    Mil Med; 2018 Jul; 183(7-8):e278-e290. PubMed ID: 29420772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overweight and obesity trends among active duty military personnel: a 13-year perspective.
    Reyes-Guzman CM; Bray RM; Forman-Hoffman VL; Williams J
    Am J Prev Med; 2015 Feb; 48(2):145-153. PubMed ID: 25442226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The burden of vestibular disorders among military health system (MHS) beneficiaries, fiscal years 2018-2019.
    Sayegh MA; Banaag A; Korona-Bailey J; Madsen C; Frank A; Koehlmoos TP
    PLoS One; 2023; 18(10):e0286798. PubMed ID: 37856452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stratified analysis of the association between anti-obesity medications and digestive adverse events: a real-world study based on the FDA adverse event reporting system database.
    Yang Q; Wang J; Wang M; Zhang S; He QQ
    BMC Pharmacol Toxicol; 2024 Sep; 25(1):64. PubMed ID: 39267168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pediatric Obesity Prevalence in the U.S. Military Health System, Fiscal Years 2012-2018.
    Bleach CC; Brooks DI; Larson NS
    Mil Med; 2024 May; 189(5-6):e1136-e1144. PubMed ID: 37930774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TRICARE Extended Care Health Option Program: Prevalence of pediatric ECHO enrollees and healthcare service utilization in the Military Health System.
    Hsu NM; Morris K; Banaag A; Koehlmoos TP
    Disabil Health J; 2023 Jul; 16(3):101451. PubMed ID: 36941191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Avoidable Hospitalizations in the Military Health System, Fiscal Years 2018-2019.
    Koehlmoos TP; Banaag A; Korona-Bailey J; Schoenfeld AJ; Weissman JS
    Mil Med; 2024 Aug; 189(9-10):e2120-e2126. PubMed ID: 38695652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BMI changes among U.S. Navy and Marine Corps active-duty service members during the COVID-19 pandemic, 2019-2021.
    Janvrin ML; Banaag A; Landry T; Vincent C; Koehlmoos TP
    BMC Public Health; 2024 Aug; 24(1):2289. PubMed ID: 39174905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and Cost Benefits of Anti-Obesity Medication for US Veterans Participating in the MOVE! Weight Management Program.
    Garvey WT; Cheng M; Ramasamy A; Smolarz BG; Park S; Kumar N; Kim N; DerSarkissian M; Bhak RH; Duh MS; Wu M; Hansen S; Young-Xu Y
    Popul Health Manag; 2023 Feb; 26(1):72-82. PubMed ID: 36735596
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.